Skip to main content Accessibility help
×
Home
  • Print publication year: 2015
  • Online publication date: September 2015

Chapter 8 - Managing Parkinson's disease patients treated with deep brain stimulation

Related content

Powered by UNSILO
1.Benazzouz, A, Hallett, M. Mechanism of action of deep brain stimulation. Neurology 2000;55(Suppl 6):1316.
2.Benabid, A, Pollak, P, Gervason, C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337(8738):403–06.
3.Benabid, AL, Chabardes, S, Mitrofanis, J, et al. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet 2009;8:6881.
4.Tykocki, T, Mandat, T, Nauman, P. Pedunculopontine nucleus deep brain stimulation in Parkinson's disease. Arch Med Sci 2011;7(4): 555–64.
5.Plaha, P, Ben-Shlomo, Y, Patel, NK, Gill, SS. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 2006;129:1732–47.
6.Schuepbach, W, Knudsen, R, Volkmann, J, et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013;368:610–22.
7.Ngoga, D, Mitchell, R, Kausar, J, et al. Deep brain stimulation improves survival in severe Parkinson's disease. J Neurol Neurosurg Psychiatry 2014;85:1722.
8.Saint-Cyr, JA, Trépanier, LL, Kumar, R, et al. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease Brain 2000;123:2091–108.
9.Merola, A, Zibetti, M, Angrisano, S, et al. Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease. Mov Disord 2011;26:664–70.
10.Henderson, JM, O'Sullivan, DJ, Pell, M, et al. Lesion of thalamic centromedian-parafascicular complex after chronic deep brain stimulation. Neurology 2001;56:1576–79.
11.The Deep Brain Stimulation for Parkinson's Disease Study Group. Deep brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956–63.
12.Witjas, T, Kaphan, E, Azulay, JP, et al. Effects of subthalamic nucleus (STN) deep brain stimulation (DBS) on non-motor fluctuation (NMF) in Parkinson's disease. Neurology 2001;56(Suppl 3):274.
13.Fasano, A, Daniele, A, Albanese, A. Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. Lancet Neurol 2012;11:429–42.
14.Marques, A, Chassin, O, Morand, D. Central pain modulation after subthalamic nucleus stimulation. Neurology 2013;81(7):633–40.
15.Sako, W, Nishio, M, Maruo, T, et al. Subthalamic nucleus deep brain stimulation for camptocormia associated with Parkinson's disease. Mov Disord 2009;24:1076–79.
16.Welter, ML, Houeto, JL, Tezenas du Montcel, S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002;125:575–83.
17.Vingerhoets, FJG, Villemure, JG, Temperli, P, et al. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 2002;58:396401.
18.Fontaine, D, Mattei, V, Borg, M, et al. Effect of subthalamic nucleus stimulation on obsessive–compulsive disorder in a patient with Parkinson disease. Case report. J Neurosurg 2004;100:1084–86.
19.Weaver, FM, Follett, KA, Stern, M, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology 2012;79(1):5565.
20.Odekerken, V, van Laar, T, Staal, M, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013:12(1):3744.
21.Uitti, RJ, Tsuboi, Y, Pooley, RA, et al. Magnetic resonance imaging and deep brain stimulation. Neurosurgery 2002;51:1423–31.
22.Larson, PS, Richardson, RM, Starr, PA, et al. Magnetic resonance imaging of implanted deep brain stimulators: experience in a large series. Stereotact Funct Neurosurg 2008;86:92100.
23.Carcieri, S, Reich, M, Steigerwald, F. Impedance changes occur during threshold measurements in deep brain stimulation patients. Neurology 2014;82(Suppl):P7.046.
24.Krack, P, Pollak, P, Limousin, P, et al. Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol 1998;43:180–92.
25.Bejjani, B, Damier, P, Arnulf, I, et al. Pallidal stimulation for Parkinson's disease. Two targets? Neurology 1997;49(1):564–69.
26.Deuschl, G, Schade-Brittinger, C, Krack, P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896908.
27.Castrioto, A, Volkman, J, Krack, P. Postoperative management of deep brain stimulation in Parkinson's disease. In: Lozano, A, Hallett, M, eds. Handbook of Clinical Neurology. Amsterdam: Elsevier B.V.; 2013, 116:129–46.
28.Castrioto, A, Kistner, A, Klinger, K, et al. Psychostimulant effect of levodopa: reversing sensitization is possible. J Neurol Neurosurg Psychiatry 2013;84:1822.
29.Kedia, S, Moro, E, Tagliati, M, Lang, AE, Kumar, R. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology 2004;63(12):2410–12.
30.Driver-Dunckley, E, Evidente, VG, Adler, CH, et al. Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation. Mov Disord 2006;21:1287–89.
31.Chung, K, Lobb, B, Nutt, J, et al. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 2010;75:1263–69.
32.Khoo, H, Kishima, H, Hosomi, K, et al. Low-frequency subthalamic nucleus stimulation in Parkinson's disease: a randomized clinical trial. Mov Disord 2011;29:270–74.
33.Moreau, C, Delval, A, Defebvre, L, et al. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol 2012;11:589–96.
34.Haynes, WI, Haber, SN. The organization of prefrontal–subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: implications for basal ganglia models and deep brain stimulation. J Neurosci 2013;33:4804–14.
35.Castrioto, A, Lhommèe, E, Krack, P, et al. Mood and behavioural effects of subthalamic stimulation. Lancet Neurol 2014;13:287305.
36.Thobois, S, Ardouin, C, Lhommée, E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010;133:1111–27.
37.Volkmann, J, Daniels, C, Witt, K. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol 2010;6:487–98.
38.Bejjani, BP, Damier, P, Arnulf, I, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999;340(19):1476–80.
39.Voon, V, Krack, P, Lang, AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008;131:2720–28.
40.Krack, P, Kumar, R, Ardouin, C, et al. Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord 2001;16:867–75.
41.Frank, M, Samanta, J, Moustafa, A, et al. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007;318:1309–12.
42.Lim, SY, O'Sullivan, S, Kotschet, K, et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 2009;9:1148–52.
43.Wu, B, Han, L, Sun, BM, et al. Influence of deep brain stimulation of the subthalamic nucleus on cognitive function in patients with Parkinson's disease. Neurosci Bull 2014;30:153–61.
44.Witt, K, Daniels, C, Reiff, J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008;7:605–14.
45.Witt, K, Granert, O, Daniels, C, et al. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial. Brain 2013;136:2109–19.
46.Rodriguez-Oroz, MC, Moro, E, Krack, P. Long-term outcomes of surgical therapies for Parkinson's disease. Mov Disord 2012;27:1718–28.
47.Hely, M, Reid, W, Adena, M. The Sydney Multicenter Study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23(6):837–44.
48.Freund, H, Kuhn, J, Lenartz, D, et al. Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch Neurol 2009;66:781–85.
49.Stefani, A, Lozano, AM, Peppe, A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007;130:1596–607.
50.Ferraye, M, Debû, B, Fraix, V, et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010;133:205–14.